BY
Mazor Robotics (NSDQ:MZOR) said today it is releasing data from 2 new studies touting the benefits of robotic assistance and surgical guidance with its Renaissance device during minimally invasive spinal surgery procedures.
The company said it presented the data at the 23rd International Meeting on Advanced Spine Techniques in Washington, D.C.
“These studies validate the clinical and economic value proposition of Renaissance by delivering the positive results that surgeons and hospital administrations expect from advanced technologies. While MIS adoption for spine surgeries is improving in general, the rate of MIS surgeries using our surgical guidance technology is far higher than the industry average, demonstrating that it is an enabling technology that delivers better patient outcomes,” CEO Ori Hadomi said in a press release.
The 1st retrospective study investigated surgical outcomes between robotically-guided and freehand procedures, and examined the outcomes of 705 patients, 403 of which underwent robotically-guided surgeries, 228 who underwent fluoscopic-guided MIS procedures and 78 who underwent fluoscopic-guided open procedures.
